AVODART (Avera McKennan Hospital)
Welcome to the PulseAid listing for the AVODART drug offered from Avera McKennan Hospital. This 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
NON-PROPRIETARY NAME: | dutasteride |
SUBSTANCE NAME: | DUTASTERIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, LIQUID FILLED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-03-23 |
END MARKETING DATE: | 0000-00-00 |
AVODART HUMAN PRESCRIPTION DRUG Details:
Item Description | AVODART from Avera McKennan Hospital |
LABELER NAME: | Avera McKennan Hospital |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/1) |
START MARKETING DATE: | 2015-03-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69189-0712_674d2b54-aabe-4d67-aa68-dfdaa1219bd0 |
PRODUCT NDC: | 69189-0712 |
APPLICATION NUMBER: | NDA021319 |
Other DUTASTERIDE Pharmaceutical Manufacturers / Labelers: